Skip to main content
SpringerLink
Log in

Perspektiven der Chemotherapie urologischer Tumoren

  • Conference paper
20. bis 23. Oktober 1982, Hamburg

Part of the book series: Verhandlungsbericht der Deutschen Gesellschaft für Urologie ((VBDGUROLOGIE,volume 34))

  • 14 Accesses

Zusammenfassung

Drei Tumorerkrankungen werden in diesem Referat besprochen, die beispielhaft das gesamte Spektrum der derzeitigen Ergebnisse der Chemotherapie maligner Erkrankungen widerspiegeln, nämlich die Möglichkeit der Kuration von Patienten mit metastasiertem Hodenkarzinom, die der Palliation bei Patienten mit Harnblasenkarzinom und die Frustration bei Patienten mit metastasiertem Nierenkarzinom.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Einhorn LA, Williams SD (1980) Chemotherapy of disseminated testicular cancer. A random prospective study. Cancer 46:1339–1344.

    Article  PubMed  CAS  Google Scholar 

  2. Vugrin D, Herr HW, Whitmore WF Jr, Sogani PC, Golbey RB (1981) VAB-6 combination chemotherapy in disseminated cancer of the testis. Ann Internal Med 95:59–61.

    CAS  Google Scholar 

  3. Scheulen ME, Higi M, Schilcher RB, Meier CR, Seeber S, Schmidt CG (1980) Sequentiell alternierende Chemotherapy nicht-seminomatöser Hodentumoren mit Velbe/Bleomycin und Adriamycin/Cisplatin. I. Ergebnisse einer randomisierten Studie bei 71 Patienten mit pulmonaler Metastasierung (Stadium IV). Klin Wschr 58:811–821.

    Article  PubMed  CAS  Google Scholar 

  4. Schmoll HJ (1982) The role of ifosfamide (IPP) in testicular cancer. Proc 13 th Int Cancer Congr, Seattle 1982, p 626.

    Google Scholar 

  5. Einhorn LH, Williams SD, Troner M, Birch R, Greco FA (1981) The role of maintenance therapy in disseminated testicular cancer. New Engl J Med 305:727–731.

    Article  PubMed  CAS  Google Scholar 

  6. Donohue JP, Einhorn LH, Williams SD (1980) Cytoreductive surgery for metastatic testis cancer: Considerations of timing and extent. J Urol 123:876–880.

    PubMed  CAS  Google Scholar 

  7. Seeber S (1982) Current concepts in the management of early and late testicular cancer. Proc 13 th Int Cancer Congr, Seattle 1982.

    Google Scholar 

  8. Blachley JD, Hill JB (1981) Renal and electrolyte disturbances associated with cisplatin. Ann Internal Med 95:628–632.

    CAS  Google Scholar 

  9. Vogelzang NJ, Bosl GJ, Johnson K, Kennedy BJ (1981) Raynaud’s phenomenon: A common toxicity after combination chemotherapy for testicular cancer. Ann Internal Med 95:288–292.

    CAS  Google Scholar 

  10. Peckham MJ, Barrett A, Husband JE, Hendry WF (1982) Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet II:678–680.

    Article  Google Scholar 

  11. Fossa SD, Wik B, Lien HH (1982) Phase II study of 4’-Epidoxorubicin in metastatic renal cancer. Cancer Treat Rep 66:1219–1221.

    PubMed  CAS  Google Scholar 

  12. Taylor SA, von Hoff DD (1982) Phase II trial of dihydroxyanthracenedione (DHAD) in advanced renal cell carcinoma. A swog study. Proc Am Soc Clin Oncol 1:118.

    Google Scholar 

  13. Fuks JZ, van Echo DA, Aisner J, Kravitz S, Wiernik PH (1980) A phase II trial of 4’-(9-acridinylamino)-methanesul-fon-m-anisidide (AMSA) in patients with renal cell carcinoma of the lung (SCCL). Proc Am Ass Cancer Res and Am Soc Clin Oncol 21:477.

    Google Scholar 

  14. Merrin CE (1979) Treatment of genitourinary tumors with cis-dichlorodiammineplatinum (II): Experience in 250 patients. Cancer Treat Rep 63:1579–1584.

    PubMed  CAS  Google Scholar 

  15. Stolbach LL, Begg CB, Hall T, Horton J (1981) Treatment of renal carcinoma: A phase III randomized trial of oral medrodyprogesterone (provera), hydroxyurea, and nafoxidine. Cancer Treat Rep 65:689–692.

    PubMed  CAS  Google Scholar 

  16. Todd RF III, Garaick MB, Canellos GP, Richie JP, Gittes RF, Mayer RJ, Skarin AT (1981) Phase I-II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma. Cancer Treat Rep 65:17–20.

    PubMed  Google Scholar 

  17. Baumgartner G, Heinz R, Arbes H, Lenzhofer R, Pridun N, Schüller J (1980) Methotrex-ate-citrovorum factor used alone and in combination chemotherapy for advanced hypernephromas. Cancer Treat Rep 64:41–45.

    PubMed  CAS  Google Scholar 

  18. Zeffren J, Yagoda A, Kelsen D, Winn R (1980) Phase I trial of a 5-day infusion of vinblastine (VLB). Proc Am Ass Cancer Res and Am Soc Clin Oncol 21:178.

    Google Scholar 

  19. Al-Sarraf M, Eyre H, Bonnet J, Saiki J, Gagliano R, Pugh R, Lehane D, Dixon D, Bottomley R (1981) A study of tamoxifen in metastatic renal cell carcinoma and the influence of certain prognostic factors: A Southwest Oncology Group Study. Cancer Treat Rep 65:447–451.

    PubMed  CAS  Google Scholar 

  20. Papac R, Luikhart S, Kirkwood J (1980) High dose tamoxifen in patients with advanced renal cell cancer and malignant melanoma. Proc Am Ass Cancer Res and Am Soc Clin Oncol 21:358.

    Google Scholar 

  21. Benedetto P, Yagoda A, Watson RC, Sogani P, Neri RO, Pertschuk LP, Fishman J, Bradlow JL (1981) Phase II trial of flutamide in hypernephroma correlation with hormone receptor sites. Proc Am Ass Cancer Res and Am Soc Clin Oncol 22:466.

    Google Scholar 

  22. Smith PH (1981) Chemotherapy of bladder cancer: A review. Cancer Treat Rep 65:173.

    Google Scholar 

  23. Herr HW (1980) Cis-diamminedichloride platinum II in the treatment of advanced bladder cancer. J Urol 123:853–855.

    PubMed  CAS  Google Scholar 

  24. Kedia KR, Gibbons C, Persky L (1981) The management of advanced bladder carcinoma. J Urol 125:655–658.

    PubMed  CAS  Google Scholar 

  25. Troner MB, Hemstreet GP (1981) Cyclo phosphamide, doxorubicin, and cisplatin (CAP) in the treatment of urothelial malignancy: A pilot study of the Southeastern Cancer Study Group. Cancer Treat Rep 65:29–32.

    PubMed  CAS  Google Scholar 

  26. Baker LH, Al-Sarraf M, Opipari M (1980) Combination chemotherapy (CAP) in patients with advanced urothelial cancers. Proc Am Ass Cancer Res and Am Soc Clin Oncol 21:429.

    Google Scholar 

  27. Einstein A, Soloway M, Corder M, Bonney W, Coombs J (1981) Diamminedichloroplatinum (DDP) VS. DDP plus cyclophosphamide (CY) for metastatic bladder carcinoma. Proc Am Ass Cancer Res and Am Soc Clin Oncol 22:461.

    Google Scholar 

  28. Blumenreich MS, Needles B, Yagoda A, Sogani P, Grabstald H, Whitmore WF Jr (1982) Intravesical cisplatin for superficial bladder tumors. Cancer 50:863–865.

    Article  PubMed  CAS  Google Scholar 

  29. Horn Y, Eidelman A, Walach N, Ilian M, Markowitz A (1982) Treatment of superficial bladder tumors in a controlled trial with adriamycin versus thio-tepa. Proc 13 th Int Cancer Congr, Seattle 1982, p 619.

    Google Scholar 

  30. Issell BF, DeFuria MD, Fandrich SE (1981) Topical mitomycin C (MMC) in thiotepa refractory non-invasive bladder cancer. Proc Am Ass Cancer Res and Am Soc Clin Oncol 22:464.

    Google Scholar 

  31. Wajsman Z, Lee F, Mac Donald S, Sandberg AA, Pontes JE (1982) Absorption studies of mitomycin C (MMC) during intravesical treatment of superficial bladder cancer. Proc Am Soc Clin Oncol 1:116.

    Google Scholar 

  32. Hall RR, Herring DW, McGill AC, Gibb I (1981) Oral methotrexate therapy for multiple superficial bladder carcinomata. Cancer Treat Rep 65:175–178.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Med. Klinik, Abt. für Onkologie und Hämatologie, Universitäts-Krankenhaus Eppendorf, Martinistraße 52, D-2000, Hamburg 20, Deutschland

    Prof. Dr. D. K. Hossfeld

Authors
  1. Prof. Dr. D. K. Hossfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abtlg. Allg. Krankenhaus Altona, Paul-Ehrlich-Straße 1, D-2000, Hamburg 50, Deutschland

    Joachim Kaufmann (Chefarzt der Urolog.) (Chefarzt der Urolog.)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hossfeld, D.K. (1983). Perspektiven der Chemotherapie urologischer Tumoren. In: Kaufmann, J. (eds) 20. bis 23. Oktober 1982, Hamburg. Verhandlungsbericht der Deutschen Gesellschaft für Urologie, vol 34. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82065-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82065-6_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-12476-4

  • Online ISBN: 978-3-642-82065-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation